-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

634. Myeloproliferative Syndromes: Clinical: Poster II

Myeloproliferative Syndromes: Clinical Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Renato Tavares, MD1*, Giuseppe A. Palumbo, MD2*, Philipp Le Coutre, MD3, Francesca Palandri, MD, PhD4*, Haifa Kathrin Al-Ali, MD5*, Bruno Martino, MD6*, Anna Marina Liberati, MD7*, Jose Grasa Ullrich, MD8*, Massimo Breccia, MD9*, David Brittain, MD10, Lynda Foltz, MD, FRCP11, Martin Griesshammer, MD12*, Pia Raanani, MD13, Vikas Gupta, MD, FRCP, FRCPath14, Pilar Giraldo, MD, PhD15, Jagannath Ghosh16*, Bayane Tannir17*, Julian Perez Ronco, MD, MBA17* and Alessandro M. Vannucchi, MD18

1Universidade Federal de Goiania, Goias, Brazil
2Division of Hematology, Ospedale Ferrarotto, University of Catania, Catania, Italy
3Charité - Universitätsmedizin Berlin, Berlin, Germany
4University of Bologna, Bologna, Italy
5University of Leipzig, Leipzig, Germany
6Az.Osp. Bianchi-Melacrino’-Morelli, Reggio Calabria, Italy
7SC Oncoematologia, Azienda Ospedaliera S. Maria, Terni, Italy
8Unidad de Hematología, Laboratorio Doctor Grasa, Zaragoza, Spain
9Dipartimento di Ematologia e Biotecnologie, Universitŕ La Sapienza, Rome, Italy
10Albert Alberts Stem Transplantation Unit, Pretoria East Hospital, Pretoria, South Africa
11St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada
12Department of Hematology and Oncology, Johannes-Wesling Clinic Minden, Minden, Germany
13Rabin Medical Center, Petah Tikva, Israel
14Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
15Miguel Servet University Hospital and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Zaragoza, Spain
16Novartis Pharmaceuticals Corporation, East Hanover, NJ
17Novartis Pharma AG, Basel, Switzerland
18University of Florence, Florence, Italy

Srdan Verstovsek, MD1, Moshe Talpaz, MD2, Ellen Ritchie, MD3, Martha Wadleigh, MD4, Olatoyosi Odenike, MD5, Catriona Jamieson, MD, PhD6, Brady Stein, MD7, Tomonori Uno, PhD8* and Ruben A. Mesa9

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI
3medicine and a member of the Leukemia Program, Cornell University, New York, NY
4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
5University of Chicago Medical Center, Chicago, IL
6Division of Regenerative Medicine, University of California, San Diego, La Jolla, CA
7Dept. of Medicine, Division of Hematology/Oncology and Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL
8NS Pharma, Inc., Paramus, NJ
9Mayo Clinic, Scottsdale, AZ

Ayalew Tefferi, MD1, Paola Guglielmelli, PhD MD2*, Terra L. Lasho, PhD3*, Yoseph Elala, MD4*, Tiziana Fanelli, MSc5*, Naseema Gangat, MBBS3, Christy Finke, BS6*, Giada Rotunno, MSc5*, Curtis A. Hanson, MD7, Rhett P. Ketterling, MD8*, Animesh Pardanani, MBBS, PhD9 and Alessandro M. Vannucchi, MD10

1Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
2CRIMM-Centro Ricerca e Innovazione delle Malattie Mieloproliferative,Department of Experimental and Clinical Medicine, Azienda Ospedaliera-Universitaria Careggi, University of Florence, Florence, Italy
3Division of Hematology, Mayo Clinic, Rochester, MN
4Mayo Clinic, Rochester
5CRIMM-Centro Ricerca e Innovazione delle Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy
6Hematology, Mayo Clinic, Rochester, MN
7Division of Hematopathology, Mayo Clinic, Rochester, MN
8Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
9Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
10University of Florence, Florence, Italy

Animesh Pardanani, MBBS, PhD1, Kaaren Reichard, MD2, Darci Zblewski, CNP3*, Ramy Abdelrahman, M.B., B.Ch.3*, Emnet Wassie, M.D.3*, William G. Morice, MD, PhD4*, Christopher L. Brooks, PhD5, Curtis A. Hanson, MD6, Ayalew Tefferi, MD3 and Dong Chen, MD, PhD7

1Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
2Laboratory Medicine and Pathology, Hematopathology Laboratory, Mayo Clinic, Rochester, MN
3Division of Hematology, Mayo Clinic, Rochester, MN
4Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
5Stemline Therapeutics, Inc., New York, NY
6Division of Hematopathology, Mayo Clinic, Rochester, MN
7Division of Hematopathology, Special Coagulation Laboratory, Mayo Clinic, Rochester, MN

Lisa Pieri, MD, PhD1,2*, Chiara Paoli, BS1,2*, Umberto Arena, MD3*, Fabio Marra, MD4*, Fabio Mori, MD5*, Mery Zucchini, MD5*, Stefano Colagrande, MD6*, Alessandro Castellani, MD6*, Arianna Masciulli, PhD, MSc7*, Vittorio Rosti, MD8, Valerio De Stefano, MD9*, Silvia Betti, MD10*, Guido Finazzi, MD11*, Maria Luisa Ferrari, BSc11*, Elisa Rumi, MD12*, Marco Ruggeri, MD13, Ilaria Nichele, MD13*, Paola Guglielmelli, MD, PhD1,2*, Rajmonda Fjerza, MD1,2*, Carmela Mannarelli, MSc1*, Tiziana Fanelli, MSc1,2*, Lucia Merli, BSN1,2*, Margherita Massa, PhD14*, Giuseppe Cimino, MD15*, Alessandro Rambaldi, MD11, Giovanni Barosi, MD8, Mario Cazzola, MD12, Tiziano Barbui, MD16* and Alessandro M. Vannucchi, MD1,2

1CRIMM-Centro Ricerca e Innovazione delle Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy
2Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
3Internal Medicine and Hepatology,, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy
4Department of Experimental and Clinical Medicine,, University of Florence, Florence, Italy
5Department of Cardiology, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy
6Radiodiagnostica 2, Dip Scienze Biomediche Sperimentali e Cliniche, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy
7Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
8Center for the Study of Myelofibrosis, Biotechnology Research Area, IRCCS Policlinico San Matteo Foundation, Pavia, Italy
9Hematology, Catholic University, Rome, Italy
10Institute of Hematology, Catholic University, Rome, Italy
11Department of Hematology, Hospital Papa Giovanni XXIII, Bergamo, Italy
12Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
13Department of Hematology, San Bortolo Hospital, Vicenza, Italy
14Biotechnology Research Area, IRCCS Policlinico San Matteo Foundation, Pavia, Italy
15S.M. Goretti, UOC Hematology, Latina, Italy
16Hospital Papa Giovanni XXIII and Research Foundation, Bergamo, Italy

Jean-Jacques Kiladjian1, Tamás Masszi, MD, PhD2, Mark M. Jones, MD3*, Brian Gadbaw, MD4, Jingjin Li, PhD4*, Dany Habr, MD4*, Alessandro M. Vannucchi, MD5 and Srdan Verstovsek, MD, PhD6

1Hôpital Saint-Louis and Paris Diderot University, Paris, France
2St. István and St. László Hospital, Budapest, Hungary
3Incyte Corporation, Wilmington, DE
4Novartis Pharmaceuticals Corporation, East Hanover, NJ
5University of Florence, Florence, Italy
6Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

A Kamel Abou Hussein, MD1, Naseema Gangat, MBBS2, Yoseph Elala, MD3*, Alexandra Wolanskyj, MD4, Curtis A. Hanson, MD1, Rhett P. Ketterling, MD5*, Animesh Pardanani, MBBS, PhD6 and Ayalew Tefferi, MD7

1Mayo Clinic, Rochester, MN
2Division of Hematology, Mayo Clinic, Rochester, MN
3Mayo Clinic, Rochester
4Mayo Clinic Mayo Building West 10, Rochester, MN
5Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
6Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
7Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN

Samer A Srour, MB ChB, MS1,2, Susan S Devesa, MD3*, Lindsay M Morton, PhD3, David P Check3*, Rochelle E Curtis, MA3*, Martha S Linet, MD, MPH3* and Graca M Dores, MD, MPH1,3

1Oklahoma City VA Health Care System, Oklahoma City, OK
2Graduate College and Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK
3Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD

Francesco Passamonti, MD1*, Martin Griesshammer, MD2*, Michele Cavo, MD3*, Miklos Egyed4, Giulia Benevolo, MD5*, Timothy Devos, MD PhD6*, Jeannie Callum, MD7, Alessandro M. Vannucchi, MD8, Serdar Sivgin, MD9*, Caroline Bensasson, PhD10*, Mahmudul Khan, PhD11*, Nadjat Mounedji, MD10* and Guray Saydam, MD, Prof12*

1Ospedale di Circolo e Fondazione Macchi, Varese, Italy
2Department of Hematology and Oncology, Johannes-Wesling Clinic Minden, Minden, Germany
3"Serŕgnoli" Institute of Hematology, University of Bologna, Bologna, Italy
4Kaposi Mór Teaching Hospital, Kaposvár, Hungary
5Cittŕ della Salute e della Scienza di, Torino, Italy
6Hematology, UZ Leuven, Leuven, Belgium
7Sunnybrook Health Sciences Centre, Toronto, Canada
8University of Florence, Florence, Italy
9Dedeman Stem Cell Transplantation Hospital, Department of Hematology, Erciyes University, Kayseri, Turkey
10Novartis Pharma S.A.S, Rueil Malmaison, France
11Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA
12Ege University Medical Faculty, Izmir, Turkey

Damien Luque Paz, MD1*, Aurelie Chauveau, MD1*, Caroline Buors, MD1*, Jean-Christophe Ianotto, MD2*, Francoise Boyer, MD3*, Laura Samaison, MD4*, Claude Ferec, MD, PhD5*, Cedric Le Marechal, MD, PhD5*, Paul Gueguen, MD6* and Valerie Ugo, MD, PhD7*

1Laboratoire Hematologie, CHU Brest, Brest, France
2Centre Hospitalier Universitaire, Brest, France
3Centre Hospitalier Universitaire, Angers, France
4Pathology Department, CHU Brest, Brest, France
5INSERM U1078, CHU Brest, Brest, France
6Laboratoire Genetique, CHU Brest, Brest, France
7Laboratoire Hematologie, CHU Angers, Angers, France

Margherita Massa, PhD1*, Rita Campanelli, BS2*, Gabriela Fois, BS2*, Laura Villani, BS,2*, Elisa Bonetti, PhD2*, Paolo Catarsi, BS2*, Valentina Poletto, PhD2*, Gianluca Viarengo, MD3*, Vittorio Rosti, MD2 and Giovanni Barosi, MD2

1Biotechnology Research Area, IRCCS Policlinico San Matteo Foundation, Pavia, Italy
2Center for the Study of Myelofibrosis, Biotechnology Research Area, IRCCS Policlinico San Matteo Foundation, Pavia, Italy
3Immunohaematology and Transfusion Service, IRCCS Policlinico San Matteo Foundation, Pavia, Italy

Srdan Verstovsek, MD1, Michael R. Savona, MD2, Ruben A. Mesa3, Stephen Oh, MD PhD4, Hua Dong, PhD5*, Dung Thai5* and Jason Gotlib, MD6

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Vanderbilt University School of Medicine, Nashville, TN
3Mayo Clinic, Scottsdale, AZ
4Division of Hematology, Washington University School of Medicine, St. Louis, MO
5Gilead Sciences, Foster City, CA
6School of Medicine/ Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA

Alessandro Andriani, MD1*, Roberto Latagliata, MD2*, Michele Cedrone, MD3*, Ambra Di Veroli, MD4*, Cristina Santoro, MD5*, Francesca Spirito6*, Carla Ruscio6*, Sabrina Crescenzi-Leonetti7*, Raffaele Porrini, MD8*, Jonny Di Giandomenico9*, Nicoletta Villivŕ1*, Antonio Spadea, MD10, Angela Rago, MD11*, Cinzia De Gregoris12*, Paolo Cercola13*, Barbara Anaclerico, MD14*, Marianna De Muro, MD15*, Stefano Felici, MD1*, Massimo Breccia, MD16*, Enrico Montefusco, MD17*, Antonino Bagnato, MD18*, Giuseppe Cimino, MD19*, Ignazio Majolino, MD20, Maria Gabriella Mazzucconi, MD21*, Giuliana Alimena, MD22 and Marco Montanaro, MD23*

1UOSA of Hematology, ASL RMA, Nuovo Regina Margherita Hospital, Rome, Italy
2Department of Hematology, University, Rome, Italy
3UOC of Hematology, San Giovanni - Addolorata Hospital, Rome, Italy
4Hematology, Tor Vergata University, Rome, Italy
5University of Rome “Sapienza”, Department of Cellular Biotechnologies and Hematology, Rome, Italy
6UOC of Hematology and bone marrow transplantation, San Camillo-Forlanini Hospital, Rome, Italy
7UOC of Hemtology, San Giovanni Hospital, Rome, Italy
8Hematology, Azienda Ospedaliera Sant'Andrea, Rome, Italy
9UOC of Hematology and bone marrow transplantation, University of PTV, Rome, Italy
10Clinical Oncology, Istituto Regina Elena, Rome, Italy
11UOC of Hematology, University, Latina, Italy
12UOC of Hematology, ASL VT, Viterbo, Italy
13ASL VT, Molecolar Laboratory, Viterbo, Italy
14Hematology, San Giovanni - Addolorata Hospital, Rome, Italy
15Hematology, Univ. Campus Bio Medieo, Rome, Italy
16. Department of Hematology, University of Rome “La Sapienza”, Rome, Italy
17Hematology Unity, Sant'Andrea Hospital, Rome, Italy
18UOC of Hematology, San Giovanni Hospital, Rome, Italy
19S.M. Goretti, UOC Hematology, Latina, Italy
20Department of Hematology, Ospedale S. Camillo, Rome, Italy
21Centro Regionale di Riferimento per l’Emofilia e Sindromi Correlate, Universitŕ Sapienza, Policlinico Umberto I, Rome, Italy
22Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
23ASL VT, UOC of Hemathology, Viterbo, Italy

Sebastian Kreil, MD, PhD1*, Lionel Adčs, MD, PhD2*, Martin Bommer, MD3*, Frank Stegelmann, MD3*, Mark E Ethell, MBBChir, MA, FRCP, FRCPath4*, Anna Lubking, MD5*, Peter Martin, MD6*, Ekkehard Eigendorff, MD7*, Wolf-Karsten Hofmann, MD1, Nicholas C.P. Cross, PhD8, Andreas Hochhaus, MD7 and Andreas Reiter, MD1*

1Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany
2Hospital St Louis, Paris 7 University, Paris, France
3Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany
4Haemato-Oncology Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom
5Department of Hematology and Vascular Disorders, Skĺne University Hospital, Lund, Sweden
6MVZ Tempelhof, Berlin, Germany
7Department of Hematology and Oncology, University Hospital Jena, Jena, Germany
8Wessex Regional Genetics Laboratory, University of Southampton, Salisbury, United Kingdom

Brady Stein, MD1, Alison Moliterno, MD2, Ralph V. Boccia, MD3, Ahmad B. Naim, MD4*, Joseph A. Cordaro, PharmD, MBA4*, Wei Peng, PhD4*, Hao Sun, MS4*, Shreekant V. Parasuraman, PhD4 and Ruben A. Mesa5

1Northwestern University Feinberg School of Medicine, Chicago, IL
2Johns Hopkins University School of Medicine, Baltimore, MD
3The Center for Cancer and Blood Disorders, Bethesda, MD
4Incyte Corporation, Wilmington, DE
5Mayo Clinic Cancer Center, Scottsdale, AZ

Veronika Buxhofer-Ausch1,2*, Michael Steurer3, Siegfried Sormann4*, Ernst Schloegel5*, Wolfgang Schimetta6*, Bettina Gisslinger7*, Reinhard Ruckser8*, Martin Schalling, MSc7*, Guenther A. Gastl, MD9 and Heinz Gisslinger, MD7

1Hospital Elisabethinen, Linz, Austria
2Medical University of Vienna, Linz, Austria
3Division of Hematology and Oncology, Innsbruck University Hospital, Innsbruck, Austria
4Medical University of Graz, Graz, Austria
5Hanusch Hospital, Vienna, Austria
6Johannes Kepler University, Linz, Austria
7Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria
8Donauspital, Vienna, Austria
9Internal Medicine V, Haematology & Oncology, Innsbruck Medical University, Innsbruck, Austria

Marco Montanaro, MD1*, Roberto Latagliata, MD2*, Michele Cedrone, MD3*, Ambra Di Veroli, MD4*, Cristina Santoro, MD5*, Francesca Spirito6*, Carla Ruscio6*, Sabrina Leonetti-Crescenzi7*, Raffaele Porrini, MD8*, Jonny Di Giandomenico9*, Nicoletta Villivŕ10*, Antonio Spadea, MD11, Angela Rago, MD12*, Cinzia De Gregoris13*, Paolo Cercola14*, Barbara Anaclerico, MD15*, Marianna De Muro, MD16*, Stefano Felici, MD10*, Massimo Breccia, MD17*, Enrico Montefusco, MD18*, Antonino Bagnato, MD7*, Giuseppe Cimino, MD19*, Ignazio Majolino, Prof20, Maria Gabriella Mazzucconi, MD21*, Giuliana Alimena, MD22 and Alessandro Andriani, MD10*

1ASL VT, UOC of Hemathology, Viterbo, Italy
2Division of Hematology-Dept. of Cellular Biotechnologies and Hematology, University La Sapienza of Rome, Rome, Italy
3UOC of Hematology, San Giovanni - Addolorata Hospital, Rome, Italy
4Hematology, Tor Vergata University, Rome, Italy
5University of Rome “Sapienza”, Department of Cellular Biotechnologies and Hematology, Rome, Italy
6UOC of Hematology and bone marrow transplantation, San Camillo-Forlanini Hospital, Rome, Italy
7UOC of Hematology, San Giovanni Hospital, Rome, Italy
8Hematology, Azienda Ospedaliera Sant'Andrea, Rome, Italy
9UOC of Hematology and bone marrow transplantation, University of PTV, Rome, Italy
10UOSA of Hematology, ASL RMA, Nuovo Regina Margherita Hospital, Rome, Italy
11Clinical Oncology, Istituto Regina Elena, Rome, Italy
12UOC of Hematology, University, Latina, Italy
13UOC of Hematology, ASL VT, Viterbo, Italy
14ASL VT, Molecolar Laboratory, Viterbo, Italy
15Hematology, San Giovanni - Addolorata Hospital, Rome, Italy
16Hematology, Univ. Campus Bio Medieo, Rome, Italy
17Dipartimento di Ematologia e Biotecnologie, Universitŕ La Sapienza, Rome, Italy
18Hematology Unity, Sant'Andrea Hospital, Rome, Italy
19S.M. Goretti, UOC Hematology, Latina, Italy
20Azienda ospedaliera S. Camillo-Forlanini, UOC di Ematologia e Trapianto di Midollo, Rome, Italy
21Centro Regionale di Riferimento per l’Emofilia e Sindromi Correlate, Universitŕ Sapienza, Policlinico Umberto I, Rome, Italy
22Department of Biotechnologies and Hematology, Sapienza University, Rome, Italy

Georg Jeryczynski, MD1*, Juergen Thiele, MD2*, Bettina Gisslinger1*, Maria Theresa Krauth, MD1*, Martin Schalling, MSc1*, Ana-Iris Schiefer, MD3*, Ingrid Simonitsch-Klupp, MD3*, Leonhard Muellauer, MD3* and Heinz Gisslinger, MD1

1Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria
2Institute of Pathology, University of Cologne, Cologne, Germany
3Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria

Alessandro M. Vannucchi, MD1, Heinz Gisslinger, MD2, Claire N. Harrison3, Haifa Kathrin Al-Ali, MD4*, Ester Pungolino, MD5*, Jean-Jacques Kiladjian6, Francoise Boyer-Perrard, MD7*, Franck E. Nicolini, MD, PhD8, Shuyuan Mo9*, Edric Atienza, MSHS9*, Prashanth Gopalakrishna, MBBS, MRCS10* and Peter A. te Boekhorst11*

1University of Florence, Florence, Italy
2Medical University of Vienna, Vienna, Austria
3Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom
4University of Leipzig, Leipzig, Germany
5Niguarda Cŕ Granda Hospital, Milan, Italy
6Hôpital Saint-Louis and Paris Diderot University, Paris, France
7Centre Hospitalier Universitaire d'Angers, Angers, France
8Centre Hospitalier Lyon Sud, Pierre-Bénite, France
9Novartis Pharmaceuticals Corporation, East Hanover, NJ
10Novartis Pharma AG, Basel, Switzerland
11Erasmus MC/Centrumlocatie, Rotterdam, Netherlands

Krisstina L. Gowin, DO1*, Tania Jain, MD1, Heidi E. Kosiorek, MS2*, John Camoriano, MD1, Raoul Tibes, MD1, Jeanne Palmer, MD1* and Ruben A. Mesa2

1Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ
2Mayo Clinic, Scottsdale, AZ

Animesh Pardanani, MBBS, PhD1, Yoseph Elala, MD2*, Rong He, MD3, Curtis A. Hanson, MD4 and Ayalew Tefferi, MD5

1Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
2Mayo Clinic, Rochester
3Division of Hematopathology, Special Coagulation Laboratory, Mayo Clinic, Rochester, MN
4Division of Hematopathology, Mayo Clinic, Rochester, MN
5Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN

Hafsa M Chaudhry, BA1*, Kenneth W Merrell, MD2*, Ayalew Tefferi, MD3 and Michelle A Neben Wittich, MD2*

1Mayo Medical School, Rochester, MN
2Mayo Clinic, Department of Radiation Oncology, Rochester, MN
3Division of Hematology, Mayo Clinic, Rochester, MN

Michele Cedrone, MD1*, Barbara Anaclerico, MD2*, Francesca Paoloni, Dr3*, Roberto Latagliata, MD4*, Marco Montanaro, MD5*, Francesca Spirito6*, Sabrina Leonetti Crescenzi, MD7*, Antonio Spadea, MD8, Raffaele Porrini, MD9*, Angela Rago, MD10*, Massimo Breccia, MD11*, Cinzia De Gregoris12*, Giuseppe Cimino, MD13*, Enrico Montefusco, MD14*, Agostino Tafuri, MD15, Giuseppe Avvisati, MD16, Ignazio Majolino, MD17, Francesco Lo Coco, MD18*, Cristina Santoro, MD19*, Maria Gabriella Mazzucconi, MD20*, Carla Ruscio6*, Marianna De Muro, MD21*, Giuliana Alimena, MD22, Alessandro Andriani, MD23*, Antonino Bagnato24* and Luciana Annino25*

1UOC of Hematology, San Giovanni - Addolorata Hospital, Rome, Italy
2Hematology, San Giovanni - Addolorata Hospital, Rome, Italy
3GIMEMA, Rome, Italy
4Division of Hematology-Dept. of Cellular Biotechnologies and Hematology, University La Sapienza of Rome, Rome, Italy
5ASL VT, UOC of Hemathology, Viterbo, Italy
6UOC of Hematology and bone marrow transplantation, San Camillo-Forlanini Hospital, Rome, Italy
7UOC Haematology, San Giovanni - Addolorata Hospital, Rome, Italy
8Clinical Oncology, Istituto Regina Elena, Rome, Italy
9Hematology, Azienda Ospedaliera Sant'Andrea, Rome, Italy
10UOC of Hematology, University, Latina, Italy
11Dipartimento di Ematologia e Biotecnologie, Universitŕ La Sapienza, Rome, Italy
12UOC of Hematology, ASL VT, Viterbo, Italy
13S.M. Goretti, UOC Hematology, Latina, Italy
14Hematology Unity, Sant'Andrea Hospital, Rome, Italy
15Hematology, Sapienza AO Sant'Andrea, Rome, Italy
16Dept. of Hematology, University Campus Bio-Medico, Rome, Italy
17Ematologia, Ospedale S. Camillo, Rome, Italy
18Hematology, University Tor Vergata, Rome, Italy
19University of Rome “Sapienza”, Department of Cellular Biotechnologies and Hematology, Rome, Italy
20Centro Regionale di Riferimento per l’Emofilia e Sindromi Correlate, Universitŕ Sapienza, Policlinico Umberto I, Rome, Italy
21Hematology, Univ. Campus Bio Medieo, Rome, Italy
22Department of Biotechnologies and Hematology, Sapienza University, Rome, Italy
23UOSA of Hematology, ASL RMA, Nuovo Regina Margherita Hospital, Rome, Italy
24UOC Haematology, San Giovanni Hospital, Rome, Italy
25S.Giovanni-Addolorata Hospital, Rome, Italy

Yin Xu, MD, PhD, Brian Kwok, MD, Aine Yung, MD, Rachel Flamholz, MD, Zhao Wu, MD, PhD, Bashar Dabbas, MD and Prashanti Reddy, MD

Genoptix, Inc., a Novartis company, Carlsbad, CA

Mario Ojeda-Uribe, MD1*, Constantin Ungureanu, MD2*, Olivier Morel, MD2*, Christophe Desterke, PhD3*, Marie-Caroline Le Bousse-Kerdiles, PhD4,5 and Hatem Boulahdour, MD, PhD6*

1Hematology and Cellular Therapy Unit, GHRMSA, Hôpital E Muller, Mulhouse, France
2Pôle d'Imagérie, Centre Hospitalier Universitaire de Besancon, Besancon, France
3U1197, INSERM, Hôpital Paul Brousse & Université Paris 11, VIllejuif, France
4Paris 11 University, Inserm U1197, Villejuif, France
5French Group of Myeloproliferative Disorders (FIM), Paris, France
6Pôle d'Imagérie, 4EA 4662-Nanomedicine Lab, Imagery and Therapeutics, Centre Hospitalier Universitaire de Besancon, Besancon, France

*signifies non-member of ASH